Bg Medicine, Inc.

Aram S Adourian

Doris Damian

Amir Handzel

Noubar Boghos Afeyan

Pieter Muntendam

Matej Oresic

Jan Van Der Greef

Eric K Neumann

Frederick E Regnier

Yu Guo

Elwin Robbert Verheij

Xiaohong Li

Biomarkers and methods are disclosed for diagnosing the risk of a myocardial infarction in an individual by measuring the levels of a set of biomarkers in a sample from an individual. A risk score is calculated for the individual by weighting the measured levels of the biomarkers. The risk score then is used to identify whether the individual is likely to experience a myocardial infarction. In addition, kits are disclosed that include a set of reagents for specifically measuring biomarker levels in a sample from an individual.

Risk factors and prediction of myocardial infarction

Markers are provided for detecting coronary artery disease. Levels of these markers are indicative of a patient being at risk of having or developing coronary artery disease.

Methods for detecting coronary artery disease

Markers are provided that are predictive of Alzheimer's disease. Levels of these markers, when different from a standard, are indicative of a patient being at risk of having or developing Alzheimer's disease.

Methods for detecting Alzheimer's disease

The present invention provides methods and systems for developing profiles of a biological system based on the discernment of similarities, differences, and/or correlations between biomolecular components of a plurality of biological samples. Preferably, the method comprises utilizing hierarchical multivariate analysis of spectrometric data at one or more levels of correlation.

Method and system for profiling biological systems

Growing community of inventors

Woburn, MA, United States of America

Aram S Adourian